Home / Facilities / 3008501562

CERAGROUP INDUSTRIES FDA Inspection Record

FEI 3008501562 · Inspections, Form 483s, warning letters and import refusals

CERAGROUP INDUSTRIES is an FDA-registered facility (FEI 3008501562) located in Fort Lauderdale, FL, US. RegDataLab tracks 5 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Apr 15, 2025: Voluntary Action Indicated (VAI)
Inspections on record
5 (3 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 15, 2025Voluntary Action Indicated (VAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50)
Oct 11, 2022No Action Indicated (NAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a))
Documented evaluation (21 CFR 820.50(a)(1))
Management review - Lack of or inadequate procedures (21 CFR 820.20(c))
Nov 25, 2019No Action Indicated (NAI)Lack of or inadequate DHR procedures (21 CFR 820.184)
Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a))
Quality Audit/Reaudit - conducted (21 CFR 820.22)
Personnel (21 CFR 820.25(a))
and 1 more
Aug 18, 2015Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Quality audits - Lack of or inadequate procedures (21 CFR 820.22)
Design control - no procedures (21 CFR 820.30(a))
Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50)
Jan 10, 2012Voluntary Action Indicated (VAI)Quality audits - Lack of or inadequate procedures (21 CFR 820.22)
Design control - no procedures (21 CFR 820.30(a))
Lack of or inadequate procedures (21 CFR 820.100(a))
Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50)
and 1 more

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 14, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 14, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 14, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 14, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 2, 2026Newest record Oct 22, 2026Current

Reviewing CERAGROUP INDUSTRIES as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check CERAGROUP INDUSTRIES yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Ceragroup Industries Inc
Location
Fort Lauderdale, FL (US)
Source
device

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.